The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.
Tan N, Wu H, Lan C, Liu C, Liao A, Jiao Z, Su D, Zhang X, Zhang Z, Xiao W, Li F, Li X, Xia M, Qiu R, Chen H, Liu Y, Su M, Chen M, Xiao Y.
Tan N, et al.
Int J Antimicrob Agents. 2024 Nov;64(5):107320. doi: 10.1016/j.ijantimicag.2024.107320. Epub 2024 Sep 16.
Int J Antimicrob Agents. 2024.
PMID: 39293772
Free article.
Clinical Trial.